Preparation of cell-derived vesicles from eukaryotic and prokaryotic origins for the delivery of biomolecules
Open Access
- 18 December 2025
- journal article
- Published by Taylor & Francis in Artificial Cells, Nanomedicine, and Biotechnology
- Vol. 54 (1) , 1-18
Abstract
Cell membrane-derived vesicles play essential roles in intercellular communication, material transport, and waste disposal. Despite their biomedical and industrial potential, isolating extracellular vesicles from natural sources remains technically challenging, limiting purification efficiency and scalability. This study introduces cell membrane extrusion as an alternative approach to optimize the production of cell membrane-derived vesicles (CSMs), from eukaryotic and prokaryotic cells. CSMs, generated from HeLa and SH-SY5Y cells exhibited a distinctive cup-shaped morphology and sizes of 151.36 ± 72.36 nm, and 416.86 ± 108.49 nm at 20 °C by DLS respectively, showing remarkable thermal stability at 4-70 °C range. Furthermore, loaded vesicles interacted with mammalian cells and achieved successful cargo internalization. CSMs were also produced from E. coli membranes, forming unilamellar vesicles of approximately 100 nm, as observed by Cryo-TEM. These vesicles displayed an inverse correlation between vesicle size and thermal stability and efficient cargo incorporation detected in 85% ± 3% of CSMs. However, under tested conditions, no interaction with prokaryotic cells occurred, and consequently, no delivery of the loaded molecule was observed. Overall, thesefindings highlight the potential of generating cell membrane-derived nanovesicles through extrusion, offering a promising strategy to mimic extracellular vesicles for innovative biomedical and industrial applications, including targeted drug delivery system.Keywords
Funding Information
- the Spanish Ministry of Science, Innovation, and Universities (MICIU) and the State Research Agency (PID2019-107298RB-C22)
This publication has 79 references indexed in Scilit:
- Recent Advances in Cancer Cell Membrane‐Based Nanoparticles and Cancer Cell‐Derived Small Extracellular Vesicles as Drug Delivery PlatformsAdvanced NanoBiomed Research, 2025
- MISEV2023: An updated guide to EV research and applicationsJournal of Extracellular Vesicles, 2024
- Bacterial Membrane Vesicles: Physiological Roles, Infection Immunology, and ApplicationsAdvanced Science, 2023
- Comparison of extruded cell nanovesicles and exosomes in their molecular cargos and regenerative potentialsNano Research, 2023
- GMP‐compliant manufacturing of biologically active cell‐derived vesicles produced by extrusion technologyJournal of Extracellular Biology, 2022
- Synergistic Therapy of a Naturally Inspired Glycopolymer‐Based Biomimetic Nanomedicine Harnessing Tumor Genomic InstabilityAdvanced Materials, 2021
- Extracellular Vesicles and Their Roles in Cancer Progression2020
- Plasmonic Cell‐Derived Nanocomposites for Light‐Controlled Cargo Release inside Living CellsAdvanced Biosystems, 2020
- Critical Evaluation of Nanoparticle Tracking Analysis (NTA) by NanoSight for the Measurement of Nanoparticles and Protein AggregatesPharmaceutical Research, 2010
- Gram‐positive bacteria produce membrane vesicles: Proteomics‐based characterization of Staphylococcus aureus ‐derived membrane vesiclesProteomics, 2009